TY - JOUR
T1 - A critical role of formyl peptide receptors in host defense against Escherichia coli
AU - Zhang, Meihua
AU - Gao, Ji Liang
AU - Chen, Keqiang
AU - Yoshimura, Teizo
AU - Liang, Weiwei
AU - Gong, Wanghua
AU - Li, Xiaoqing
AU - Huang, Jiaqiang
AU - McDermott, David H.
AU - Murphy, Philip M.
AU - Wang, Xietong
AU - Wang, Ji Ming
N1 - Funding Information:
Received for publication April 12, 2019. Accepted for publication February 12, 2020. This work was supported by federal funds from the National Cancer Institute (NCI), National Institutes of Health (NIH) under Contract HSN261200800001E and by the Intramural Research Programs of the NCI and the National Institute of Allergy and Infectious Diseases, NIH. M.Z. was also supported in part by National Natural Science Foundation of China Grant 81873842, Shandong University, Jinan, People’s Republic of China.
Publisher Copyright:
© 2020 by The American Association of Immunologists, Inc.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Formyl peptide receptors (FPRs, mouse Fprs) belong to the G protein-coupled receptor superfamily and mediate phagocyte migration in response to bacteria- and host-derived chemoattractants; however, knowledge about their in vivo roles in bacterial pathogenesis is limited. In this study, we investigated the role of Fpr1 and Fpr2 in host defense against Escherichia coli infection. In vitro, we found that supernatants from E. coli cultures induced chemotaxis of wild-type (WT) mouse bone marrow-derived neutrophils and that the activity was significantly reduced in cells genetically deficient in either Fpr1 or Fpr2 and was almost absent in cells lacking both receptors. Consistent with this, E. coli supernatants induced chemotaxis and MAPK phosphorylation in HEK293 cells expressing either recombinant Fpr1 or Fpr2 but not untransfected parental cells. WT bone marrow -derived neutrophils could actively phagocytose and kill E. coli, whereas both activities were diminished in cells lacking Fpr1 or Fpr2; again, an additive effect was observed in cells lacking both receptors. In vivo, Fpr1 and Fpr2 deficiency resulted in reduced recruitment of neutrophils in the liver and peritoneal cavity of mice infected with inactivated E. coli. Moreover, Fpr12/2 and Fpr2-/- mice had significantly increased mortality compared with WT mice after i.p. challenge with a virulent E. coli clinical isolate. These results indicate a critical role of Fprs in host defense against E. coli infection.
AB - Formyl peptide receptors (FPRs, mouse Fprs) belong to the G protein-coupled receptor superfamily and mediate phagocyte migration in response to bacteria- and host-derived chemoattractants; however, knowledge about their in vivo roles in bacterial pathogenesis is limited. In this study, we investigated the role of Fpr1 and Fpr2 in host defense against Escherichia coli infection. In vitro, we found that supernatants from E. coli cultures induced chemotaxis of wild-type (WT) mouse bone marrow-derived neutrophils and that the activity was significantly reduced in cells genetically deficient in either Fpr1 or Fpr2 and was almost absent in cells lacking both receptors. Consistent with this, E. coli supernatants induced chemotaxis and MAPK phosphorylation in HEK293 cells expressing either recombinant Fpr1 or Fpr2 but not untransfected parental cells. WT bone marrow -derived neutrophils could actively phagocytose and kill E. coli, whereas both activities were diminished in cells lacking Fpr1 or Fpr2; again, an additive effect was observed in cells lacking both receptors. In vivo, Fpr1 and Fpr2 deficiency resulted in reduced recruitment of neutrophils in the liver and peritoneal cavity of mice infected with inactivated E. coli. Moreover, Fpr12/2 and Fpr2-/- mice had significantly increased mortality compared with WT mice after i.p. challenge with a virulent E. coli clinical isolate. These results indicate a critical role of Fprs in host defense against E. coli infection.
UR - http://www.scopus.com/inward/record.url?scp=85084037912&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084037912&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1900430
DO - 10.4049/jimmunol.1900430
M3 - Article
C2 - 32221037
AN - SCOPUS:85084037912
SN - 0022-1767
VL - 204
SP - 2464
EP - 2473
JO - Journal of Immunology
JF - Journal of Immunology
IS - 9
ER -